Company Filing History:
Years Active: 2013-2014
Title: Innovations in Cancer Immunotherapy by Jiali Li
Introduction
Jiali Li is a prominent inventor based in Monterey Park, California, known for her significant contributions to the field of cancer immunotherapy. With a total of two patents to her name, she has been at the forefront of developing innovative therapeutic agents aimed at combating cancer.
Latest Patents
Jiali Li's latest patents focus on compositions and methods for cancer immunotherapy. One of her notable inventions includes a cancer therapeutic agent that comprises a cancer targeting molecule linked to a liver-expressed chemokine (LEC). In this embodiment, the cancer targeting molecule is an antibody that specifically targets cancer cells or tumors in vivo. The association of the cancer targeting molecule with LEC can be either non-covalent or covalent. These therapeutic agents are designed to treat cancer by reducing tumor size or inhibiting the growth of cancer cells, as well as preventing the development of metastasis. The effectiveness of these therapies can be enhanced by reducing the activity of immunoregulatory T cells or by adoptively transferring immune T cells.
Career Highlights
Jiali Li is affiliated with the University of Southern California, where she continues to advance her research in cancer treatment. Her work has garnered attention for its potential to significantly improve patient outcomes in cancer therapy.
Collaborations
Jiali Li collaborates with esteemed colleagues such as Alan L Epstein and Peisheng Hu, contributing to a dynamic research environment focused on innovative cancer treatments.
Conclusion
Jiali Li's work in cancer immunotherapy exemplifies the impact of innovative research on medical science. Her patents represent a significant step forward in the fight against cancer, showcasing her dedication to improving therapeutic options for patients.